Amplification of c-erbB-2 in gastric cancer: Detection in formalin- fixed, paraffin-embedded tissue by fluorescence in situ hybridization

Laboratory Investigation

Volumn 78, Issue 3, 1998, Pages 345-351

  Ooi, Akishi ^a   Kobayashi, Masako ^a   Mai, Masayoshi ^a   Nakanishi, Isao ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; CHROMOSOME 17P; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; FIXATIVES; FORMALDEHYDE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PARAFFIN EMBEDDING; RECEPTOR, ERBB-2; STOMACH NEOPLASMS;

EID: 0031931368     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The American Joint Committee on Cancer (1997). Stomach. In: Beahrs OH and Myers MH, editors. Manual for staging of cancer, 5th ed. New York: Lippincott-Raven, pp 71-74.
2. Bar-Am I, Mor O, Yeger H, Shiloh Y, and Avivi L (1992). Detection of amplified DNA sequences in human tumor cell lines by fluorescence in situ hybridization. Genes Chromosome Cancer 4:314-320.
3. Bosher JM, Williams T, and Hurst HC (1995). The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92:744-747.
4. Brison O (1993). Gene amplification and tumor progression. Biochim Biophys Acta 1155:25-41.
5. Coene ED, Schelfhout V, Winkler RA, Schelfhout A-M, Van Roy N, Grooteclaes M, Speleman F, and De Potter CR (1997). Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer. Virchows Arch 430:365-372.
6. Fantl V, Richards MA, Smith R, Lammie GA, Johnstone G, Allen D, Gregory W, Peters G, Dickson C, and Barnes DM (1990). Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 26:423-429.
7. Ishikawa T, Kobayashi M, Mai M, Suzuki T, and Ooi A (1997). Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells: Detection by fluorescence in situ hybridization. Am J Pathol 151:761-768.
8. Jain S, Filipe MI, Gullick WJ, Linehan J, and Morris RW (1991). c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival material. Int J Cancer 48:668-671.
9. The Japanese Research Society for Gastric Cancer (1981a). The general rules for the gastric cancer study in surgery and pathology: Part I - Clinical classification. Jpn J Surg 11:127-139.
10. The Japanese Research Society for Gastric Cancer. Committee on Histological Classification of Gastric Cancer (1981b). The general rules for the gastric cancer study in surgery and pathology: Part II - Histological classification of gastric cancer. Jpn J Surg 11:140-145.
11. Koizumi Y, Tanaka S, Mou R, Koganei H, Kokawa A, Kitamura R, Yamauchi H, Ookubo K, Saito T, Tominaga S, Matsumura K, Shimada H, Tsuchida N, and Sekihara H (1997). Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin Cancer Res 3:1067-1076.
12. Lemoine NR, Staddon S, Dickson C, Barnes DM, and Gullick WJ (1990). Absence of activating point mutation in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene 5:237-239.
13. Leong PK, Thorner P, Yeger H, Ng K, Zhang Z, and Squire J (1993). Detection of MYCN gene amplification and deletion of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Lab Invest 69:43-50.
14. Liscia DS, Merlo GR, Garrett C, French D, Mariani-Costantini R, and Callahan R (1989). Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 4:1219-1224.
15. Misra DN, Dickman PS, and Yunis EJ (1995). Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. Diagn Mol Pathol 4:128-135.
16. Nowell PC (1976). The clonal evolution of tumor cell populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194:23-28.
17. Pasleau F, Grooteclaes M, and Gol-Winkler R (1993). Expression of the c-erbB-2 gene in the BT-474 human mammary tumor cell line: Measurement of c-erbB-2 mRNA half-life. Oncogene 8:849-854.
18. Ranzani GN, Pellegata NS, Previdere C, Saragoni A, Vio A, Maltoni M, and Amadori D (1990). Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res 50:7811-7814.
19. Ruiz JC and Wahl GM (1990). Chromosomal destabilization during gene amplification. Mol Cell Biol 10:3056-3066.
20. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, and Waldman F (1994). Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508-514.
21. Sauter G, Maeda T, Waldman FM, Davis RL, and Feuerstein BG (1996). Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148:1047-1053.
22. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, and Look AT (1993). Detection of N-myc gene amplification by fluorescence in situ hybridization: Diagnostic utility for neuroblastoma. Am J Pathol 142:1339-1346.
23. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, and Press MF (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
24. Tateishi M, Toda T, Minamisono Y, and Nagasaki S (1992). Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. J Surg Oncol 49:209-212.
25. Teixeria MR, Pandis N, Bardi G, Andersen JA, Mitelman F, and Heim S (1995). Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra- and extratumorous samples from three patients. Int J Cancer 63:63-68.
26. Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, Kobayashi M, and Hirohashi S (1993). Overexpression of c-erbB-2 protein in gastric cancer: Its correlation with long-term survival of patients. Cancer 72:3179-3184.
27. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M, and Sasaki T (1991). Expression of c-erbB-2 oncoprotein in gastric carcinoma: Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer 67:2914-2918.